The assessment of the ability of combined treatment of bone marrow stromal cells graft (BMSCs) and oral administration of Coenzyme (CoQ10) in rat model of Parkinson disease as a good substitute for common current Parkinson treatments and the comparison of this combined treatment method with alone application of these treatments

In this experimental study of male Wistar rats were used. They were divided into six groups: control sham lesion treatment groups with oral administration of CoQ10 treatment with graft BMSC and combined treatment with graft BMSC and oral administration of CoQ10. Oral administration of CoQ10 with 200 mg/kg/daily dose started a week before the model creation procedure and continued throughout the whole treatment period. The laboratory model of Parkinson disease in rats was performed by injecting 2.5 microlitre saline solution 0.9 % containing 8 micrograms 6-hydroxy dopamine (6-OHDA) and 0.2 % ascorbic acid in substantia nigra pars compacta. Also in sham group the same volume solution saline-ascorbic was injected. BMS Cells were labeled by 5-Bromo-2´-deoxyuridine (Brdu) before transplantation. Behavioral assessment before creating the model two weeks after creating the model and eight weeks after cell transplantation was performed. At the end of second month of treatment Immunohistochemistry and histology Studies were performed.

Behavioral assessment of two groups of alone treatments indicated the equal recovery in comparison with lesion group (p